India to Germany: Hydroxychloroquine Export Trade Route
India has recorded 30 verified shipments of Hydroxychloroquine exported to Germany, representing a combined trade value of $1.7M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $57.0K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 64% of total export value with 26 shipments worth $1.1M USD. On the buying side, NA is the largest importer in Germany with $1.5M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Germany Hydroxychloroquine corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $1.7M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's hydroxychloroquine manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $57.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with hydroxychloroquine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 32.5%, placing it at rank #14 among India's top hydroxychloroquine export destinations globally.
On the import side, key buyers of Indian hydroxychloroquine in Germany include NA, HANSE SERVICE INTERNATIONALE FRACHT SPEDITION GMBH. NA is the single largest importer with 26 shipments valued at $1.5M USD.
Route Characteristics
- Average transit26 days
